Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Lysosomal Alpha Glucosidase Market Growth 2022-2028

  • LP 4922970
  • 102 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Lysosomal Alpha Glucosidase will have significant change from previous year. According to our (LP Information) latest study, the global Lysosomal Alpha Glucosidase market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Lysosomal Alpha Glucosidase market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Lysosomal Alpha Glucosidase market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lysosomal Alpha Glucosidase market, reaching US$ million by the year 2028. As for the Europe Lysosomal Alpha Glucosidase landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Lysosomal Alpha Glucosidase players cover Amicus Therapeutics Inc, Audentes Therapeutics Inc, Etubics Corp, and Genzyme Corp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Lysosomal Alpha Glucosidase market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

AT-982

ATB-200

AVRRD-03

JR-162

MOSS-GAA

OXY-2810

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Glycogen Storage Disease

Pompe Disease

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Amicus Therapeutics Inc

Audentes Therapeutics Inc

Etubics Corp

Genzyme Corp

greenovation Biotech GmbH

Huons Co Ltd

JCR Pharmaceuticals Co Ltd

Oxyrane Belgium NV

Pharming Group NV

Sarepta Therapeutics Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Lysosomal Alpha Glucosidase Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Lysosomal Alpha Glucosidase by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Lysosomal Alpha Glucosidase by Country/Region, 2017, 2022 & 2028

2.2 Lysosomal Alpha Glucosidase Segment by Type

2.2.1 AT-982

2.2.2 ATB-200

2.2.3 AVRRD-03

2.2.4 JR-162

2.2.5 MOSS-GAA

2.2.6 OXY-2810

2.2.7 Others

2.3 Lysosomal Alpha Glucosidase Sales by Type

2.3.1 Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)

2.3.2 Global Lysosomal Alpha Glucosidase Revenue and Market Share by Type (2017-2022)

2.3.3 Global Lysosomal Alpha Glucosidase Sale Price by Type (2017-2022)

2.4 Lysosomal Alpha Glucosidase Segment by Application

2.4.1 Glycogen Storage Disease

2.4.2 Pompe Disease

2.4.3 Others

2.5 Lysosomal Alpha Glucosidase Sales by Application

2.5.1 Global Lysosomal Alpha Glucosidase Sale Market Share by Application (2017-2022)

2.5.2 Global Lysosomal Alpha Glucosidase Revenue and Market Share by Application (2017-2022)

2.5.3 Global Lysosomal Alpha Glucosidase Sale Price by Application (2017-2022)

3 Global Lysosomal Alpha Glucosidase by Company

3.1 Global Lysosomal Alpha Glucosidase Breakdown Data by Company

3.1.1 Global Lysosomal Alpha Glucosidase Annual Sales by Company (2020-2022)

3.1.2 Global Lysosomal Alpha Glucosidase Sales Market Share by Company (2020-2022)

3.2 Global Lysosomal Alpha Glucosidase Annual Revenue by Company (2020-2022)

3.2.1 Global Lysosomal Alpha Glucosidase Revenue by Company (2020-2022)

3.2.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Company (2020-2022)

3.3 Global Lysosomal Alpha Glucosidase Sale Price by Company

3.4 Key Manufacturers Lysosomal Alpha Glucosidase Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Lysosomal Alpha Glucosidase Product Location Distribution

3.4.2 Players Lysosomal Alpha Glucosidase Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Lysosomal Alpha Glucosidase by Geographic Region

4.1 World Historic Lysosomal Alpha Glucosidase Market Size by Geographic Region (2017-2022)

4.1.1 Global Lysosomal Alpha Glucosidase Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Lysosomal Alpha Glucosidase Annual Revenue by Geographic Region

4.2 World Historic Lysosomal Alpha Glucosidase Market Size by Country/Region (2017-2022)

4.2.1 Global Lysosomal Alpha Glucosidase Annual Sales by Country/Region (2017-2022)

4.2.2 Global Lysosomal Alpha Glucosidase Annual Revenue by Country/Region

4.3 Americas Lysosomal Alpha Glucosidase Sales Growth

4.4 APAC Lysosomal Alpha Glucosidase Sales Growth

4.5 Europe Lysosomal Alpha Glucosidase Sales Growth

4.6 Middle East & Africa Lysosomal Alpha Glucosidase Sales Growth

5 Americas

5.1 Americas Lysosomal Alpha Glucosidase Sales by Country

5.1.1 Americas Lysosomal Alpha Glucosidase Sales by Country (2017-2022)

5.1.2 Americas Lysosomal Alpha Glucosidase Revenue by Country (2017-2022)

5.2 Americas Lysosomal Alpha Glucosidase Sales by Type

5.3 Americas Lysosomal Alpha Glucosidase Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Lysosomal Alpha Glucosidase Sales by Region

6.1.1 APAC Lysosomal Alpha Glucosidase Sales by Region (2017-2022)

6.1.2 APAC Lysosomal Alpha Glucosidase Revenue by Region (2017-2022)

6.2 APAC Lysosomal Alpha Glucosidase Sales by Type

6.3 APAC Lysosomal Alpha Glucosidase Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Lysosomal Alpha Glucosidase by Country

7.1.1 Europe Lysosomal Alpha Glucosidase Sales by Country (2017-2022)

7.1.2 Europe Lysosomal Alpha Glucosidase Revenue by Country (2017-2022)

7.2 Europe Lysosomal Alpha Glucosidase Sales by Type

7.3 Europe Lysosomal Alpha Glucosidase Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Lysosomal Alpha Glucosidase by Country

8.1.1 Middle East & Africa Lysosomal Alpha Glucosidase Sales by Country (2017-2022)

8.1.2 Middle East & Africa Lysosomal Alpha Glucosidase Revenue by Country (2017-2022)

8.2 Middle East & Africa Lysosomal Alpha Glucosidase Sales by Type

8.3 Middle East & Africa Lysosomal Alpha Glucosidase Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Lysosomal Alpha Glucosidase

10.3 Manufacturing Process Analysis of Lysosomal Alpha Glucosidase

10.4 Industry Chain Structure of Lysosomal Alpha Glucosidase

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Lysosomal Alpha Glucosidase Distributors

11.3 Lysosomal Alpha Glucosidase Customer

12 World Forecast Review for Lysosomal Alpha Glucosidase by Geographic Region

12.1 Global Lysosomal Alpha Glucosidase Market Size Forecast by Region

12.1.1 Global Lysosomal Alpha Glucosidase Forecast by Region (2023-2028)

12.1.2 Global Lysosomal Alpha Glucosidase Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Lysosomal Alpha Glucosidase Forecast by Type

12.7 Global Lysosomal Alpha Glucosidase Forecast by Application

13 Key Players Analysis

13.1 Amicus Therapeutics Inc

13.1.1 Amicus Therapeutics Inc Company Information

13.1.2 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered

13.1.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amicus Therapeutics Inc Main Business Overview

13.1.5 Amicus Therapeutics Inc Latest Developments

13.2 Audentes Therapeutics Inc

13.2.1 Audentes Therapeutics Inc Company Information

13.2.2 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered

13.2.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Audentes Therapeutics Inc Main Business Overview

13.2.5 Audentes Therapeutics Inc Latest Developments

13.3 Etubics Corp

13.3.1 Etubics Corp Company Information

13.3.2 Etubics Corp Lysosomal Alpha Glucosidase Product Offered

13.3.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Etubics Corp Main Business Overview

13.3.5 Etubics Corp Latest Developments

13.4 Genzyme Corp

13.4.1 Genzyme Corp Company Information

13.4.2 Genzyme Corp Lysosomal Alpha Glucosidase Product Offered

13.4.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Genzyme Corp Main Business Overview

13.4.5 Genzyme Corp Latest Developments

13.5 greenovation Biotech GmbH

13.5.1 greenovation Biotech GmbH Company Information

13.5.2 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Offered

13.5.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 greenovation Biotech GmbH Main Business Overview

13.5.5 greenovation Biotech GmbH Latest Developments

13.6 Huons Co Ltd

13.6.1 Huons Co Ltd Company Information

13.6.2 Huons Co Ltd Lysosomal Alpha Glucosidase Product Offered

13.6.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Huons Co Ltd Main Business Overview

13.6.5 Huons Co Ltd Latest Developments

13.7 JCR Pharmaceuticals Co Ltd

13.7.1 JCR Pharmaceuticals Co Ltd Company Information

13.7.2 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Offered

13.7.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 JCR Pharmaceuticals Co Ltd Main Business Overview

13.7.5 JCR Pharmaceuticals Co Ltd Latest Developments

13.8 Oxyrane Belgium NV

13.8.1 Oxyrane Belgium NV Company Information

13.8.2 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Offered

13.8.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Oxyrane Belgium NV Main Business Overview

13.8.5 Oxyrane Belgium NV Latest Developments

13.9 Pharming Group NV

13.9.1 Pharming Group NV Company Information

13.9.2 Pharming Group NV Lysosomal Alpha Glucosidase Product Offered

13.9.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Pharming Group NV Main Business Overview

13.9.5 Pharming Group NV Latest Developments

13.10 Sarepta Therapeutics Inc

13.10.1 Sarepta Therapeutics Inc Company Information

13.10.2 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered

13.10.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Sarepta Therapeutics Inc Main Business Overview

13.10.5 Sarepta Therapeutics Inc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Lysosomal Alpha Glucosidase Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Lysosomal Alpha Glucosidase Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of AT-982

Table 4. Major Players of ATB-200

Table 5. Major Players of AVRRD-03

Table 6. Major Players of JR-162

Table 7. Major Players of MOSS-GAA

Table 8. Major Players of OXY-2810

Table 9. Major Players of Others

Table 10. Global Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)

Table 11. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)

Table 12. Global Lysosomal Alpha Glucosidase Revenue by Type (2017-2022) & ($ million)

Table 13. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2017-2022)

Table 14. Global Lysosomal Alpha Glucosidase Sale Price by Type (2017-2022) & (USD/Pcs)

Table 15. Global Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)

Table 16. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)

Table 17. Global Lysosomal Alpha Glucosidase Revenue by Application (2017-2022)

Table 18. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2017-2022)

Table 19. Global Lysosomal Alpha Glucosidase Sale Price by Application (2017-2022) & (USD/Pcs)

Table 20. Global Lysosomal Alpha Glucosidase Sales by Company (2020-2022) & (K Pcs)

Table 21. Global Lysosomal Alpha Glucosidase Sales Market Share by Company (2020-2022)

Table 22. Global Lysosomal Alpha Glucosidase Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Lysosomal Alpha Glucosidase Revenue Market Share by Company (2020-2022)

Table 24. Global Lysosomal Alpha Glucosidase Sale Price by Company (2020-2022) & (USD/Pcs)

Table 25. Key Manufacturers Lysosomal Alpha Glucosidase Producing Area Distribution and Sales Area

Table 26. Players Lysosomal Alpha Glucosidase Products Offered

Table 27. Lysosomal Alpha Glucosidase Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Lysosomal Alpha Glucosidase Sales by Geographic Region (2017-2022) & (K Pcs)

Table 31. Global Lysosomal Alpha Glucosidase Sales Market Share Geographic Region (2017-2022)

Table 32. Global Lysosomal Alpha Glucosidase Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Lysosomal Alpha Glucosidase Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Lysosomal Alpha Glucosidase Sales by Country/Region (2017-2022) & (K Pcs)

Table 35. Global Lysosomal Alpha Glucosidase Sales Market Share by Country/Region (2017-2022)

Table 36. Global Lysosomal Alpha Glucosidase Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Lysosomal Alpha Glucosidase Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)

Table 39. Americas Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)

Table 40. Americas Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)

Table 42. Americas Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)

Table 43. Americas Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)

Table 44. Americas Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)

Table 45. Americas Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)

Table 46. APAC Lysosomal Alpha Glucosidase Sales by Region (2017-2022) & (K Pcs)

Table 47. APAC Lysosomal Alpha Glucosidase Sales Market Share by Region (2017-2022)

Table 48. APAC Lysosomal Alpha Glucosidase Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Lysosomal Alpha Glucosidase Revenue Market Share by Region (2017-2022)

Table 50. APAC Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)

Table 51. APAC Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)

Table 52. APAC Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)

Table 53. APAC Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)

Table 54. Europe Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)

Table 55. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)

Table 56. Europe Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)

Table 58. Europe Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)

Table 59. Europe Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)

Table 60. Europe Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)

Table 61. Europe Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)

Table 69. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Lysosomal Alpha Glucosidase

Table 71. Key Market Challenges & Risks of Lysosomal Alpha Glucosidase

Table 72. Key Industry Trends of Lysosomal Alpha Glucosidase

Table 73. Lysosomal Alpha Glucosidase Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Lysosomal Alpha Glucosidase Distributors List

Table 76. Lysosomal Alpha Glucosidase Customer List

Table 77. Global Lysosomal Alpha Glucosidase Sales Forecast by Region (2023-2028) & (K Pcs)

Table 78. Global Lysosomal Alpha Glucosidase Sales Market Forecast by Region

Table 79. Global Lysosomal Alpha Glucosidase Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Lysosomal Alpha Glucosidase Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Americas Lysosomal Alpha Glucosidase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Lysosomal Alpha Glucosidase Sales Forecast by Region (2023-2028) & (K Pcs)

Table 84. APAC Lysosomal Alpha Glucosidase Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Lysosomal Alpha Glucosidase Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Europe Lysosomal Alpha Glucosidase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Lysosomal Alpha Glucosidase Sales Forecast by Country (2023-2028) & (K Pcs)

Table 88. Middle East & Africa Lysosomal Alpha Glucosidase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Lysosomal Alpha Glucosidase Sales Forecast by Type (2023-2028) & (K Pcs)

Table 90. Global Lysosomal Alpha Glucosidase Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Lysosomal Alpha Glucosidase Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Lysosomal Alpha Glucosidase Sales Forecast by Application (2023-2028) & (K Pcs)

Table 94. Global Lysosomal Alpha Glucosidase Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Lysosomal Alpha Glucosidase Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Application (2023-2028)

Table 97. Amicus Therapeutics Inc Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 98. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered

Table 99. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Amicus Therapeutics Inc Main Business

Table 101. Amicus Therapeutics Inc Latest Developments

Table 102. Audentes Therapeutics Inc Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 103. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered

Table 104. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Audentes Therapeutics Inc Main Business

Table 106. Audentes Therapeutics Inc Latest Developments

Table 107. Etubics Corp Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 108. Etubics Corp Lysosomal Alpha Glucosidase Product Offered

Table 109. Etubics Corp Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Etubics Corp Main Business

Table 111. Etubics Corp Latest Developments

Table 112. Genzyme Corp Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 113. Genzyme Corp Lysosomal Alpha Glucosidase Product Offered

Table 114. Genzyme Corp Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Genzyme Corp Main Business

Table 116. Genzyme Corp Latest Developments

Table 117. greenovation Biotech GmbH Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 118. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Offered

Table 119. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. greenovation Biotech GmbH Main Business

Table 121. greenovation Biotech GmbH Latest Developments

Table 122. Huons Co Ltd Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 123. Huons Co Ltd Lysosomal Alpha Glucosidase Product Offered

Table 124. Huons Co Ltd Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Huons Co Ltd Main Business

Table 126. Huons Co Ltd Latest Developments

Table 127. JCR Pharmaceuticals Co Ltd Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 128. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Offered

Table 129. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. JCR Pharmaceuticals Co Ltd Main Business

Table 131. JCR Pharmaceuticals Co Ltd Latest Developments

Table 132. Oxyrane Belgium NV Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 133. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Offered

Table 134. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Oxyrane Belgium NV Main Business

Table 136. Oxyrane Belgium NV Latest Developments

Table 137. Pharming Group NV Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 138. Pharming Group NV Lysosomal Alpha Glucosidase Product Offered

Table 139. Pharming Group NV Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Pharming Group NV Main Business

Table 141. Pharming Group NV Latest Developments

Table 142. Sarepta Therapeutics Inc Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors

Table 143. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered

Table 144. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Sarepta Therapeutics Inc Main Business

Table 146. Sarepta Therapeutics Inc Latest Developments

List of Figures

Figure 1. Picture of Lysosomal Alpha Glucosidase

Figure 2. Lysosomal Alpha Glucosidase Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Lysosomal Alpha Glucosidase Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Lysosomal Alpha Glucosidase Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Lysosomal Alpha Glucosidase Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of AT-982

Figure 10. Product Picture of ATB-200

Figure 11. Product Picture of AVRRD-03

Figure 12. Product Picture of JR-162

Figure 13. Product Picture of MOSS-GAA

Figure 14. Product Picture of OXY-2810

Figure 15. Product Picture of Others

Figure 16. Global Lysosomal Alpha Glucosidase Sales Market Share by Type in 2021

Figure 17. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2017-2022)

Figure 18. Lysosomal Alpha Glucosidase Consumed in Glycogen Storage Disease

Figure 19. Global Lysosomal Alpha Glucosidase Market: Glycogen Storage Disease (2017-2022) & (K Pcs)

Figure 20. Lysosomal Alpha Glucosidase Consumed in Pompe Disease

Figure 21. Global Lysosomal Alpha Glucosidase Market: Pompe Disease (2017-2022) & (K Pcs)

Figure 22. Lysosomal Alpha Glucosidase Consumed in Others

Figure 23. Global Lysosomal Alpha Glucosidase Market: Others (2017-2022) & (K Pcs)

Figure 24. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)

Figure 25. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application in 2021

Figure 26. Lysosomal Alpha Glucosidase Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Lysosomal Alpha Glucosidase Revenue Market Share by Company in 2021

Figure 28. Global Lysosomal Alpha Glucosidase Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Lysosomal Alpha Glucosidase Revenue Market Share by Geographic Region in 2021

Figure 30. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2017-2022)

Figure 31. Global Lysosomal Alpha Glucosidase Revenue Market Share by Country/Region in 2021

Figure 32. Americas Lysosomal Alpha Glucosidase Sales 2017-2022 (K Pcs)

Figure 33. Americas Lysosomal Alpha Glucosidase Revenue 2017-2022 ($ Millions)

Figure 34. APAC Lysosomal Alpha Glucosidase Sales 2017-2022 (K Pcs)

Figure 35. APAC Lysosomal Alpha Glucosidase Revenue 2017-2022 ($ Millions)

Figure 36. Europe Lysosomal Alpha Glucosidase Sales 2017-2022 (K Pcs)

Figure 37. Europe Lysosomal Alpha Glucosidase Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Lysosomal Alpha Glucosidase Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Lysosomal Alpha Glucosidase Revenue 2017-2022 ($ Millions)

Figure 40. Americas Lysosomal Alpha Glucosidase Sales Market Share by Country in 2021

Figure 41. Americas Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2021

Figure 42. United States Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Lysosomal Alpha Glucosidase Sales Market Share by Region in 2021

Figure 47. APAC Lysosomal Alpha Glucosidase Revenue Market Share by Regions in 2021

Figure 48. China Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country in 2021

Figure 55. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2021

Figure 56. Germany Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2021

Figure 63. Egypt Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Lysosomal Alpha Glucosidase in 2021

Figure 69. Manufacturing Process Analysis of Lysosomal Alpha Glucosidase

Figure 70. Industry Chain Structure of Lysosomal Alpha Glucosidase

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390